A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB0942 in Healthy Japanese and Caucasian Subjects
Clinical trial NCT03168984 · COMPLETED
Trial details
- NCT number
- NCT03168984
- Sponsor
- UCB Biopharma S.P.R.L.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-05
- Primary completion
- 2017-08-14
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.